7T7A

Crystal Structure of Human SHOC2: A Leucine-Rich Repeat Protein

7T7A の概要

• エントリーDOI: 10.2210/pdb7t7a/pdb
• 分子名称: Leucine-rich repeat protein SHOC-2, MAGNESIUM ION, NITRATE ION, ... (4 entities in total)
• 機能のキーワード: scaffold, leucine-rich, structural protein
• 由来する生物種: Homo sapiens (human)
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 111330.96

構造登録者

Hajian, B.,Lemke, C.,Kwon, J.,Bian, Y.,Fuller, C.,Aguirre, J. (登録日: 2021-12-14, 公開日: 2022-05-04, 最終更新日: 2024-05-22)

主引用文献

Kwon, J.J.,Hajian, B.,Bian, Y.,Young, L.C.,Amor, A.J.,Fuller, J.R.,Fraley, C.V.,Sykes, A.M.,So, J.,Pan, J.,Baker, L.,Lee, S.J.,Wheeler, D.B.,Mayhew, D.L.,Persky, N.S.,Yang, X.,Root, D.E.,Barsotti, A.M.,Stamford, A.W.,Perry, C.K.,Burgin, A.,McCormick, F.,Lemke, C.T.,Hahn, W.C.,Aguirre, A.J.
Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complex.
Nature, 609:408-415, 2022

PubMed Abstract: Receptor tyrosine kinase (RTK)-RAS signalling through the downstream mitogen-activated protein kinase (MAPK) cascade regulates cell proliferation and survival. The SHOC2-MRAS-PP1C holophosphatase complex functions as a key regulator of RTK-RAS signalling by removing an inhibitory phosphorylation event on the RAF family of proteins to potentiate MAPK signalling. SHOC2 forms a ternary complex with MRAS and PP1C, and human germline gain-of-function mutations in this complex result in congenital RASopathy syndromes. However, the structure and assembly of this complex are poorly understood. Here we use cryo-electron microscopy to resolve the structure of the SHOC2-MRAS-PP1C complex. We define the biophysical principles of holoenzyme interactions, elucidate the assembly order of the complex, and systematically interrogate the functional consequence of nearly all of the possible missense variants of SHOC2 through deep mutational scanning. We show that SHOC2 binds PP1C and MRAS through the concave surface of the leucine-rich repeat region and further engages PP1C through the N-terminal disordered region that contains a cryptic RVXF motif. Complex formation is initially mediated by interactions between SHOC2 and PP1C and is stabilized by the binding of GTP-loaded MRAS. These observations explain how mutant versions of SHOC2 in RASopathies and cancer stabilize the interactions of complex members to enhance holophosphatase activity. Together, this integrative structure-function model comprehensively defines key binding interactions within the SHOC2-MRAS-PP1C holophosphatase complex and will inform therapeutic development .

PubMed: 35831509
DOI: 10.1038/s41586-022-04928-2

実験手法

X-RAY DIFFRACTION (1.79 Å)